StonvexLoading…
StonvexStonvexStonvexCore line items from TAK's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-03-31 | Annual 2024 2024-03-31 | Annual 2023 2023-03-31 | Annual 2022 2022-03-31 |
|---|---|---|---|---|
Revenue | ¥4.58T | ¥4.26T | ¥4.03T | ¥3.57T |
Operating Income | ¥342.59B | ¥214.07B | ¥490.50B | ¥460.84B |
Net Income | ¥108.14B | ¥144.20B | ¥317.04B | ¥230.17B |
EPS (Diluted) | ¥67.23 | ¥91.16 | ¥201.94 | ¥145.87 |
Total Assets | ¥14.25T | ¥15.11T | ¥13.96T | ¥13.18T |
Total Liabilities | ¥7.31T | ¥7.83T | ¥7.60T | ¥7.49T |
Cash & Equivalents | ¥385.11B | ¥457.80B | ¥533.53B | ¥849.70B |
Free Cash Flow OCF − CapEx | ¥856.39B | ¥540.92B | ¥836.50B | ¥999.85B |
Shares Outstanding | 1.59B | 1.58B | 1.58B | 1.58B |